What are the advantages of topical roflumilast over traditional topical corticosteroids in the treatment of psoriasis?
Featuring Andrew Alexis, MD, MPH | Vice-Chair for Diversity and Inclusion, Dept. of DermatologyProfessor of Clinical Dermatology Weill Cornell MedicineNew York, NY | Published September 28, 2022
Related Media
Powered by Polaris TM